More than 70% of patients taking GLP-1 medications reported reduced alcohol cravings, a decreased desire to drink, a reduction in how much alcohol they drink per week, fewer drinks per drinking session, and reduced binge drinking compared to prior to starting treatment compared to the control group that was not taking GLP-1 medications
Available in a Tirzepatide 40mg vial or Tirzepatide 40mg pen format, this research-grade peptide ensures consistent potency and reliable results for scientific study
GLP-1 medications (semaglutide and tirzepatide) are injected under the skin (subcutaneous), not into muscle Compounded GLP-1 medications come in multi-dose vials and require a syringe for accurate dosing Correct dosing is critical using a GLP-1 dose-to-units calculator helps prevent common mistakes The abdomen is the most commonly used injection site, but the thigh and upper arm are also safe options Rotate injection sites weekly to reduce irritation and improve medication absorption Always clean the injection site and remove air bubbles before injecting Never use medication that has been exposed to heat, sunlight, or freezing temperatures (especially important in Florida) Follow your healthcare providers instructions for dosing, storage, and injection technique GLP-1 medications are injectable treatments used for weight loss and metabolic support
How It Works Compounded Tirzepatide (GLP-1/GIP) is a once-weekly injectable therapy that mimics dual incretin hormones, potentially offering stronger support for appetite regulation and metabolic balance than GLP-1 alone
Cork et al., 2015
